Citation Impact
Citing Papers
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Fundamentals and advances in magnesium alloy corrosion
2017 Standout
A comprehensive map of molecular drug targets
2016 Standout
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Role of Oncogenes and Tumor-suppressor Genes in Carcinogenesis: A Review
2020 Standout
Analysis of Cancer Metabolism by Imaging Hyperpolarized Nuclei: Prospects for Translation to Clinical Research
2011
Large volume serial section tomography by Xe Plasma FIB dual beam microscopy
2015
The molecular machinery of regulated cell death
2019 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer
2016
Strategies to Inhibit Myc and Their Clinical Applicability
2017
From machine learning to deep learning: progress in machine intelligence for rational drug discovery
2017
Drug repurposing: progress, challenges and recommendations
2018 Standout
Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma
2017
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
2018 StandoutNobel
IGF-1R inhibition enhances radiosensitivity and delays double-strand break repair by both non-homologous end-joining and homologous recombination
2013
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Tumour heterogeneity and resistance to cancer therapies
2017 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Objective assessment of cancer genes for drug discovery
2012
Hypoxia‐inducing factors as master regulators of stemness properties and altered metabolism of cancer‐ and metastasis‐initiating cells
2013
Artificial intelligence in drug discovery and development
2020 Standout
Small Cell Lung Cancer: Will Recent Progress Lead to Improved Outcomes?
2015
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Zinc-sensitive MRI contrast agent detects differential release of Zn(II) ions from the healthy vs. malignant mouse prostate
2016
Identify potential drugs for cardiovascular diseases caused by stress-induced genes in vascular smooth muscle cells
2016
Modeling and Targeting MYC Genes in Childhood Brain Tumors
2017
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
2014 Standout
Works of Yann Jamin being referenced
Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma
2015
CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs
2012
The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN -Amplified Neuroblastoma In Vivo
2011
Hyperpolarized 13C magnetic resonance detection of carboxypeptidase G2 activity
2009
The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function
2012
MRI measurements of vessel calibre in tumour xenografts: Comparison with vascular corrosion casting
2012
Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma
2013
Dependence of Wilms tumor cells on signaling through insulin-like growth factor 1 in an orthotopic xenograft model targetable by specific receptor inhibition
2012
Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors
2016
Diffusion‐weighted MRI for early detection and characterization of prostate cancer in the transgenic adenocarcinoma of the mouse prostate model
2015